Details

Vseživljenjskost v visokošolskem izobraževanju : diplomsko delo
ID Urek, Lidija (Author), ID Jelenc-Krašovec, Sabina (Mentor) More about this mentor... This link opens in a new window

This document has no files.
This document may have a phisical copy in the library of the organization, check the status via COBISS. Link is opened in a new window

Language:Slovenian
Keywords:diplomska dela, andragogika, izobraževanje odraslih, visokošolsko izobraževanje, vseživljenjsko učenje, pedagoška metodologija
Work type:Undergraduate thesis
Typology:2.11 - Undergraduate Thesis
Organization:FF - Faculty of Arts
Place of publishing:Ljubljana
Publisher:[L. Urek]
Year:2010
Number of pages:87 str.
PID:20.500.12556/RUL-112107 This link opens in a new window
UDC:374.7
COBISS.SI-ID:42282594 This link opens in a new window
Publication date in RUL:22.10.2019
Views:2652
Downloads:0
Metadata:XML DC-XML DC-RDF
:
UREK, Lidija, 2010, Vseživljenjskost v visokošolskem izobraževanju : diplomsko delo [online]. Bachelor’s thesis. Ljubljana : L. Urek. [Accessed 24 March 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=112107
Copy citation
Share:Bookmark and Share

Similar documents

Similar works from RUL:
  1. Pomen tumorskih matičnih celic in epitelno-mezenhimskega prehoda pri napredovanju nedrobnoceličnega raka pljuč
  2. Gene expression levels of the prolyl hydroxylase domain proteins PHD1 and PHD2 but not PHD3 are decreased in primary tumours and correlate with poor prognosis of patients with surgically resected non-small-cell lung cancer
  3. Proučevanje izražanja gena za fosfatidiletanolamin-N-metiltransferazo v nedrobnoceličnem pljučnem rakavem tkivu
  4. Uporabnost imunohistokemičnega določanja mutacij receptorja za epidermalni rastni faktor pri raku pljuč
  5. Sladkorna bolezen in športna vadba
Similar works from other Slovenian collections:
  1. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer
  2. Outsourcing predictive biomarker testing in non-small cell carcinoma
  3. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  4. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. NSCLC molecular testing in Central and Eastern European countries

Back